Form 8-K - Current report:
SEC Accession No. 0001493152-25-011082
Filing Date
2025-03-21
Accepted
2025-03-21 08:05:38
Documents
15
Period of Report
2025-03-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40224
2 ex99-1.htm EX-99.1 93357
3 ex99-1_001.jpg GRAPHIC 7718
  Complete submission text file 0001493152-25-011082.txt   329684

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE pulm-20250321.xsd EX-101.SCH 3017
5 XBRL LABEL FILE pulm-20250321_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE pulm-20250321_pre.xml EX-101.PRE 22360
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3685
Mailing Address 945 CONCORD STREET SUITE 1217 FRAMINGHAM MA 01701
Business Address 945 CONCORD STREET SUITE 1217 FRAMINGHAM MA 01701 (888) 355-4440
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

EIN.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36199 | Film No.: 25758566
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)